Published in Cell Tissue Res on April 12, 2013
Coronin 1 regulates cognition and behavior through modulation of cAMP/protein kinase A signaling. PLoS Biol (2014) 0.82
EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy Research. Neural Plast (2015) 0.77
Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors. Neurotoxicology (2016) 0.75
Depression: a new animal model sensitive to antidepressant treatments. Nature (1977) 8.76
Working memory. Science (1992) 8.56
A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res (1988) 7.29
Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci (2001) 7.25
The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci (2005) 7.13
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry (2007) 6.59
Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev (1966) 6.35
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Animal models of neuropsychiatric disorders. Nat Neurosci (2010) 5.78
Conditional control of gene expression in the mouse. Nat Rev Genet (2001) 5.30
Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci (2000) 5.30
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) (2002) 4.78
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain (2001) 4.44
Impaired recognition memory in rats after damage to the hippocampus. J Neurosci (2000) 4.07
A simple objective technique for measuring flexibility in thinking. J Gen Psychol (1948) 4.00
Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res (1986) 3.86
Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav (2004) 3.69
Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry (1982) 3.66
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev (2005) 3.32
Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem (2008) 3.23
Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus. J Comp Physiol Psychol (1959) 3.07
Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol (2007) 3.05
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
Learned helplessness. Annu Rev Med (1972) 2.84
Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology (1975) 2.76
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1988) 2.51
Can social interaction be used to measure anxiety? Br J Pharmacol (1978) 2.50
T-maze alternation in the rodent. Nat Protoc (2006) 2.38
On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem (2004) 2.37
Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev (2000) 2.29
Sex bias in trials and treatment must end. Nature (2010) 2.28
Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res (1983) 2.11
Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse (1987) 2.08
An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev (2004) 1.97
Sex differences in schizophrenia. Int Rev Psychiatry (2010) 1.96
The environment and susceptibility to schizophrenia. Prog Neurobiol (2010) 1.94
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry (1994) 1.90
Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res (2004) 1.85
The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav Brain Res (2008) 1.84
Like mother, like daughter: evidence for non-genomic transmission of parental behavior and stress responsivity. Prog Brain Res (2001) 1.83
Dissociating executive functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci (1996) 1.80
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry (1976) 1.78
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70
A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry (2009) 1.69
Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol (1997) 1.69
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Semin Cell Dev Biol (2002) 1.62
Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.62
"Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol (1978) 1.61
Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev (2012) 1.60
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther (2010) 1.57
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav Neurosci (2007) 1.56
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res (2001) 1.54
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory. Behav Neurosci (2007) 1.48
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull (2009) 1.45
Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull (1987) 1.41
Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci (2010) 1.40
SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry (2010) 1.36
Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci (1996) 1.36
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res (2000) 1.34
Sex differences and correlations in a virtual Morris water task, a virtual radial arm maze, and mental rotation. Behav Brain Res (2004) 1.33
All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther (2011) 1.30
A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev (2007) 1.29
Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis (1988) 1.27
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res (2007) 1.23
Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) (2004) 1.22
Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: evidence for Wagner's dual-process memory model. Neuropsychologia (2010) 1.22
The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev (2000) 1.20
Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct (2009) 1.20
Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull (1990) 1.20
Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry (2000) 1.19
Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev (2004) 1.18
The quantitative assessment of motor activity in mania and schizophrenia. J Affect Disord (2010) 1.18
Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res (2007) 1.15
ACOUSTIC VARIABLES IN THE MODIFICATION OF STARTLE REACTION IN THE RAT. J Comp Physiol Psychol (1965) 1.14
Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience (2009) 1.13
Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res (2009) 1.10
Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci (1999) 1.10
The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci (2003) 1.09
Perseveration in schizophrenia. Schizophr Bull (1997) 1.07
Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am (1968) 1.07
Neural substrates of latent inhibition: the switching model. Psychol Bull (1990) 1.06
Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res (2006) 1.05
Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology (2011) 1.04
The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp Neurol (2010) 1.03
Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? Neuropharmacology (2011) 1.02
Learning impairments of hippocampal-lesioned mice in a paddling pool. Behav Neurosci (2002) 1.01
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) (2009) 1.01
On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci (2008) 1.00
Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl) (2001) 1.00
Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol (2005) 1.80
Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol (2005) 1.37
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem (2011) 1.01
Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci (2007) 1.00
The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex. Psychopharmacology (Berl) (2008) 1.00
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition. Biochem Pharmacol (2011) 0.98
Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1. Pharmacol Biochem Behav (2008) 0.93
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. J Clin Invest (2012) 0.87
Impacts of forebrain neuronal glycine transporter 1 disruption in the senescent brain: evidence for age-dependent phenotypes in Pavlovian learning. Behav Neurosci (2010) 0.86
Sensorimotor gating is disrupted by acute but not chronic systemic exposure to caffeine in mice. Psychopharmacology (Berl) (2014) 0.77
Sensorimotor gating and vigilance-dependent choice accuracy: a within-subject correlative analysis in wild-type C57BL/6 mice. Behav Brain Res (2010) 0.75
Caffeine impairs the acquisition and retention, but not the consolidation of Pavlovian conditioned freezing in mice. Psychopharmacology (Berl) (2014) 0.75